Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
26/02/2026 06:32
Feb 26 (Reuters) - NextCell Pharma AB NXTCL.ST: Q4 OPERATING INCOME AMOUNTED TO 1,826 (3,095) TSEK Q4 LOSS AFTER FINANCIAL ITEMS -13,786 TSEK BOARD OF DIRECTORS PROPOSES THAT NO DIVIDEND SHALL BE PAID FOR FINANCIAL YEAR Source text: ID:nWkr5BGkfs Further company coverage: NXTCL.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln